abstract |
The present invention provides a pharmaceutical composition for the treatment and / or prevention of fibrosis-related diseases in vertebrates. The composition comprises at least one activin antagonist, and optionally a pharmaceutically acceptable carrier, adjuvant and / or diluent. Also, methods for treating fibrosis-related diseases in vertebrates, methods for diagnosing such conditions, and kits therefor. [Selection figure] None |